Patent application number | Description | Published |
20080280962 | NOVEL THIAZOLIDIN-4-ONE DERIVATIVES - The invention relates to pharmaceutical compositions containing at least one thiazolidin-4-one derivative to prevent or treat disorders associated with an activated immune system. Furthermore, the invention relates to novel thiazolidin-4-one derivatives notably for use as pharmaceutically active compounds. Said compounds particularly act also as immunosuppressive agents. | 11-13-2008 |
20080300294 | Novel Thiophene Derivatives - The invention relates to novel thiophene derivatives, their preparation and their use as pharmaceutically active compounds. Said compounds particularly act as immunosuppressive agents. | 12-04-2008 |
20080318955 | Novel Thiophene Derivatives as Sphingosine-1-Phosphate-1 Receptor Agonists - The invention relates to novel thiophene derivatives, their preparation and their use as pharmaceutically active compounds. Said compounds particularly act as immunosuppressive agents. | 12-25-2008 |
20090005421 | Novel Pyridine Derivatives - The invention relates to novel pyridine derivatives, their preparation and their use as pharmaceutically active compounds. Said compounds particularly act as immunosuppressive agents. | 01-01-2009 |
20090275625 | NOVEL THIAZOLIDIN 4-ONE DERIVATIVES - The invention relates to pharmaceutical compositions containing at least one thiazolidin-4-one derivative to prevent or treat disorders associated with an activated immune system. Furthermore, the invention relates to novel thiazolidin-4-one derivatives notably for use as pharmaceutically active compounds. Said compounds particularly act also as immunosuppressive agents. | 11-05-2009 |
20100048648 | Thiophene derivatives as S1P1/EDGE1 receptor agonists - The invention relates to novel thiophene derivatives, their preparation and their use as pharmaceutically active compounds. Said compounds particularly act as immunomodulating agents. | 02-25-2010 |
20100063108 | Pyridin-4-yl derivatives as immunomodulating agents - The invention relates to pyridine derivatives of Formula (I) wherein A, R | 03-11-2010 |
20100075946 | NOVEL THIOPHENE DERIVATIVES - The invention relates to novel thiophene derivatives, their preparation and their use as pharmaceutically active compounds. Said compounds particularly act as immunosuppressive agents. | 03-25-2010 |
20100087417 | AMINO-PYRIDINE DERIVATIVES AS S1P1 /EDG1 RECEPTOR AGONISTS - The invention relates to novel amino-pyridine derivatives, their preparation and their use as pharmaceutically active compounds. Said compounds particularly act as immunomodulating agents. | 04-08-2010 |
20100087495 | PHENYL DERIVATIVES AND THEIR USE AS IMMUNOMODULATORS - The invention relates to phenyl derivatives of formula (I), their preparation and their use as pharmaceutically active compounds. Said compounds particularly act as immunomodulating agents. | 04-08-2010 |
20100168005 | Pyridin-3-yl derivatives as immunomodulating agents - The invention relates to pyridin-3-yl derivatives of Formula (I) wherein R | 07-01-2010 |
20100204198 | HYDROGENATED BENZO (C) THIOPHENE DERIVATIVES AS IMMUNOMODULATORS - The invention relates to novel thiophene derivatives, their preparation and their use as pharmaceutically active compounds. Said compounds particularly act as immunosuppressive agents. | 08-12-2010 |
20100234346 | NOVEL PYRIMIDINE DERIVATIVES - The invention relates to novel pyrimidine derivatives, their preparation and their use as pharmaceutically active compounds. Said compounds particularly act as immunomodulating agents. Formula (I) wherein A represents Formula (II), Formula (III), Formula (IV), Formula (V), Formula (VI), Formula (VII), Formula (VIII) or Formula (IX) | 09-16-2010 |
20100240717 | NOVEL THIOPHENE DERIVATIVES AS S1P1/EDG1 RECEPTOR AGONISTS - The invention relates to thiophene derivatives of formula (I)/their preparation and their use as pharmaceutically active compounds. Said compounds particularly act as immunosuppressive agents wherein: A represents *—CO—CH═CH—, *—CO—CH | 09-23-2010 |
20100261702 | THIOPHENE DERIVATIVES AS AGONISTS OF S1P1/EDG1 - The invention relates to novel thiophene derivatives (1), their preparation and their use as pharmaceutically active compounds.Said compounds particularly act as immunomodulating agents. Formula (I). | 10-14-2010 |
20100331372 | PYRIDIN-2-YL DERIVATIVES AS IMMUNOMODULATING AGENTS - The invention relates to pyridine derivatives of Formula (I) | 12-30-2010 |
20110028448 | PYRIDINE COMPOUNDS - The invention relates to pyridine compounds, their preparation and their use as pharmaceutically active compounds. Said compounds particularly act as immunomodulating agents. | 02-03-2011 |
20110028449 | NOVEL AMINOMETHYL BENZENE DERIVATIVES - The invention relates to novel aminomethyl benzene derivatives, their preparation and their use as pharmaceutically active compounds. Said compounds particularly act as immunomodulating agents. | 02-03-2011 |
20110046170 | NOVEL PYRIMIDINE-PYRIDINE DERIVATIVES - The invention relates to novel pyrimidine-pyridine derivatives, their preparation and their use as pharmaceutically active compounds. Said compounds particularly act as immunomodulating agents. | 02-24-2011 |
20110212998 | PYRIDINE DERIVATIVES AS S1P1/EDG1 RECEPTOR MODULATORS - The invention relates to novel pyridine derivatives of formula (D, their preparation and their use as pharmaceutically active compounds. Said compounds particularly act as immunomodulating agents. Formula (I) wherein A represents and the other substituents are as defined in the claims. | 09-01-2011 |
20120302612 | NOVEL THIAZOLIDIN-4-ONE DERIVATIVES - The invention relates to pharmaceutical compositions containing at least one thiazolidin-4-one derivative to prevent or treat disorders associated with an activated immune system. Furthermore, the invention relates to novel thiazolidin-4-one derivatives notably for use as pharmaceutically active compounds. Said compounds particularly act also as immunosuppressive agents. | 11-29-2012 |
20130310432 | NOVEL THIAZOLIDIN-4-ONE-DERIVATIVES - The invention relates to pharmaceutical compositions containing at least one thiazolidin-4-one derivative to prevent or treat disorders associated with an activated immune system. Furthermore, the invention relates to novel thiazolidin-4-one derivatives notably for use as pharmaceutically active compounds. Said compounds particularly act also as immunosuppressive agents. | 11-21-2013 |